DIRECTIONAL TRANSPORT OF MULV GLYCOPROTEINS
DIRECTIONAL TRANSPORT OF MULV GLYCOPROTEINS
批准号:
3164990
负责人:
RICHARD W COMPANS
金额:
$10.81万
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-06-01 至 1990-06-30
关键词:
Retroviridae Retroviridae disease basolateral membrane gene expression genetic manipulation genetic recombination genetic translation immunofluorescence technique messenger RNA molecular oncology murine leukemia virus neoplasm /cancer genetics nucleocapsid temperature sensitive mutant tissue /cell culture viral leukemogenesis virus envelope virus genetics virus infection mechanism virus replication viruslike particle
中文摘要
我们的目标是确定膜的分子基础
糖蛋白被定向运输到特定的细胞
地点 这些调查将使用病毒
糖蛋白被转运到不同的质膜结构域,
极化上皮细胞表面。 识别分选信号
负责糖蛋白的定向运输,我们将分析
特异性修饰和序列置换对
确定所得分子的细胞位置。 这些
将对病毒糖蛋白进行研究,
方向和跨膜拓扑结构:gp 70/p15 E糖蛋白的
小鼠白血病病毒,一种双位点膜糖蛋白,
由疏水残基锚定的信号序列,
分子的C-末端,以及可能与其结合的gPr-gag糖蛋白。
以相反的方向锚定到膜上。 为了
描述了MuLV糖蛋白的细胞内转运途径,我们
将使用特异性抗血清来鉴定参与
糖蛋白从高尔基复合体向质膜的移动。
我们将确定两种MuLV编码的糖蛋白gp 70/p15 E和p15 E是否与MuLV的表达有关。
gPr-gag存在于相同的运输囊泡群体中,
它们是否在质膜上相互结合。 到
进一步定义参与确定病毒的病毒成分,
逆转录病毒在上皮细胞中的成熟位点,我们将研究
在产生病毒核心的细胞中病毒装配和释放的位点
在没有病毒糖蛋白的情况下,并确定
用病毒糖蛋白补充这些细胞,
顶膜或基底膜。 除了提供更好的
了解基本的细胞过程,拟议的研究应该
有助于我们了解病毒感染的发病机制
通过阐明病毒成分靶向
特定地点。
英文摘要
Our objective is to define the molecular basis by which membrane
glycoproteins are directionally transported to specific cellular
locations. These investigations will be carried out using viral
glycoproteins which are transported to different plasma membrane domains on
surfaces of polarized epithelial cells. To identify sorting signals
responsible for the directional transport of glycoproteins, we will analyze
the effects of specific modifications and sequence substitutions on
determining the cellular location of the resulting molecules. These
studies will be carried out with viral glycoproteins which exhibit distinct
orientations and transmembrane topology: the gp70/p15E glycoprotein of
murine leukemia viruses, a bitopic membrane glycoprotein with a cleaved
signal sequence that is anchored by hydrophobic residues near the
C-terminus of the molecule, and the gPr-gag glycoprotein which is likely to
be anchored to membranes in the opposite orientation. In order to
characterize the intracellular transport pathway of MuLV glycoproteins, we
will use specific antisera to identify transport vesicles involved in
movement of glycoproteins from the Golgi complex to the plasma membrane.
We will determine whether the two MuLV-encoded glycoproteins gp70/p15E and
gPr-gag are present in the same population of transport vesicles and
whether they are associated with one another on the plasma membrane. To
further define the viral components which are involved in determining the
maturation site of retroviruses in epithelial cells, we will investigate
the site of virus assembly and release in cells which produce viral cores
in the absence of viral glycoproteins, and determine the effects of
supplementing these cells with viral glycoproteins directed to either the
apical or basolateral membranes. In addition to providing a better
understanding of basic cellular processes, the proposed studies should
contribute to our knowledge concerning the pathogenesis of viral infections
by elucidating the mechanisms by which viral components are targeted to
particular locations.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Skin Vaccination Against Influenza in the Young And Aged
-
批准号:9210049
-
项目类别:
-
资助金额:$67.49万
-
财政年份:2015
-
负责人:RICHARD W COMPANS
-
依托单位:
Skin Vaccination Against Influenza in the Young And Aged
-
批准号:8886505
-
项目类别:
-
资助金额:$70.29万
-
财政年份:2015
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8257884
-
项目类别:
-
资助金额:$99.15万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8650780
-
项目类别:
-
资助金额:$102.71万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8463750
-
项目类别:
-
资助金额:$94.84万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC)
-
批准号:8357468
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8076663
-
项目类别:
-
资助金额:$96.61万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
A dual vaccine strategy against filovirus infection
-
批准号:8837557
-
项目类别:
-
资助金额:$120.24万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
VLP VACCINES FOR HIV PREVENTION
-
批准号:8357486
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:8278665
-
项目类别:
-
资助金额:$49.29万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC)
-
批准号:8172422
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:8471051
-
项目类别:
-
资助金额:$46.33万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:8075656
-
项目类别:
-
资助金额:$49.22万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
REGULATION OF MEMBRANE FUSION
-
批准号:8172444
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
Design of HIV VLPs with Enhanced Immunogenicity
-
批准号:7988855
-
项目类别:
-
资助金额:$49.72万
-
财政年份:2010
-
负责人:RICHARD W COMPANS
-
依托单位:
REGULATION OF MEMBRANE FUSION
-
批准号:7958272
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2009
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC
-
批准号:7958248
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2009
-
负责人:RICHARD W COMPANS
-
依托单位:
Novel VLP vaccines for pandemic influenza virus
-
批准号:7914758
-
项目类别:
-
资助金额:$16.29万
-
财政年份:2009
-
负责人:RICHARD W COMPANS
-
依托单位:
Novel Vaccine Strategies Against Ebola Virus
-
批准号:7372039
-
项目类别:
-
资助金额:$38.35万
-
财政年份:2008
-
负责人:RICHARD W COMPANS
-
依托单位:
INFLUENZA PATHOGENESIS & IMMUNOLOGY RESEARCH CENTER (IPIRC
-
批准号:7715853
-
项目类别:
-
资助金额:$3.56万
-
财政年份:2008
-
负责人:RICHARD W COMPANS
-
依托单位: